JI Jinggang, LIU Haiyong, SUN Liwei, ZHAO Junqing, GU Xuechang, ZUO Ruiju, CAO Liqiu, BU Yuhui. Risk classification of plasma β2-microglobulin, high-CRP, HCY and peripheral atherosclerosis disease[J]. Medical Reserch and Education, 2015, 32(2): 40-43.
[1] AIT-OUFELLA H, TALEB S, MALLAT Z, et al. Cytokine network and T cell immunity in atherosclerosis[J]. Semin Immunopathol, 2009, 31(1): 23-33.
[2] ROOKE T W, HIRSCH A T, MISRA S, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2011, 124: 2020-2045.
[3] 王俊, 钱钧, 许萍萍. 高同型半胱氨酸血症致动脉粥样硬化的发病机制及血浆浓度影响因素[J]. 内蒙古中医药, 2012,31(21): 119 - 121.
[4] 刘华勇, 潘国洲. 血清同型半胱氨酸及 C-反应蛋白对冠心病的临床价值[J]. 临床医学, 2013, 33(3): 47-48.
[5] 付伟光, 齐振勇, 李爱军, 等. HCY, Hs-CRP, LP 及 DD 联合检测在冠心病病程中的应用研究[J]. 现代预防医学, 2014, 41(1): 75-79.